Literature DB >> 22189198

Helicobacter pylori infection, chronic atrophic gastritis and major cardiovascular events: a population-based cohort study.

Ben Schöttker1, Mariam A Adamu, Melanie N Weck, Heiko Müller, Hermann Brenner.   

Abstract

OBJECTIVE: There is debate whether infection with Helicobacter (H.) pylori, the main inducer of chronic atrophic gastritis (CAG), is a risk factor for cardiovascular disease and premature mortality.
METHODS: Serological measurements of H. pylori infection and pepsinogen (PG) I and II were obtained in a population-based German cohort of 9953 older adults (50-74 years). Cox regression was employed to estimate hazard ratios (HR) and 95% confidence intervals (CI) for myocardial infarction, stroke, cardiovascular and all-cause mortality during five-year follow-up.
RESULTS: According to serology, 4977 participants (51.9%) were infected with H. pylori (2604 with cytotoxin-associated gene A (cagA) strains) and 541 (5.7%) had CAG (PGI<70 ng/mL and PGI/PGII<3). During follow-up, 540 participants died (163 from cardiovascular causes), 170 experienced a primary myocardial infarction and 241 had a stroke. Neither cytotoxin-associated gene A (cagA) negative nor cagA positive H. pylori infections were associated with an increased risk for myocardial infarction, stroke or all-cause mortality. Intriguingly, infection with cagA positive H. pylori strains was inversely associated with cardiovascular mortality (HR, 0.62; CI: 0.41-0.94). No statistically significant associations were observed for the small group of participants with CAG, but point estimates of adjusted HRs for myocardial infarction, stroke and cardiovascular mortality were all below 1 (0.71, 0.59 and 0.65, respectively).
CONCLUSIONS: Our results do not support the hypothesis that H. pylori infection or CAG are risk factors for cardiovascular disease or mortality and instead suggest an inverse relationship of cagA positive H. pylori infection with fatal cardiovascular events.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22189198     DOI: 10.1016/j.atherosclerosis.2011.11.029

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  29 in total

1.  Association of H. pylori infection with chronic kidney disease among Chinese adults.

Authors:  Xianglei Kong; Dayu Xu; Feng Li; Xiaojing Ma; Hong Su; Dongmei Xu
Journal:  Int Urol Nephrol       Date:  2017-01-02       Impact factor: 2.370

Review 2.  Extraintestinal manifestations of Helicobacter pylori: a concise review.

Authors:  Frank Wong; Erin Rayner-Hartley; Michael F Byrne
Journal:  World J Gastroenterol       Date:  2014-09-14       Impact factor: 5.742

Review 3.  Prophylactic use of aspirin: systematic review of harms and approaches to mitigation in the general population.

Authors:  Mangesh A Thorat; Jack Cuzick
Journal:  Eur J Epidemiol       Date:  2014-11-25       Impact factor: 8.082

4.  Helicobacter pylori Infection Status Correlates with Serum Parameter Levels Responding to Multi-organ Functions.

Authors:  Yuehua Gong; Wang Wei; Liu Jingwei; Dong Nannan; Yuan Yuan
Journal:  Dig Dis Sci       Date:  2015-01-20       Impact factor: 3.199

5.  Susceptibility to Helicobacter pylori infection: results of an epidemiological investigation among gastric cancer patients.

Authors:  Nikola Panic; Elena Mastrostefano; Emanuele Leoncini; Roberto Persiani; Dario Arzani; Rosarita Amore; Riccardo Ricci; Federico Sicoli; Stefano Sioletic; Milutin Bulajic; Domenico D' Ugo; Walter Ricciardi; Stefania Boccia
Journal:  Mol Biol Rep       Date:  2014-02-14       Impact factor: 2.316

6.  Helicobacter pylori vs coronary heart disease - searching for connections.

Authors:  Magdalena Chmiela; Adrian Gajewski; Karolina Rudnicka
Journal:  World J Cardiol       Date:  2015-04-26

Review 7.  Infectious burden and atherosclerosis: A clinical issue.

Authors:  Rosa Sessa; Marisa Di Pietro; Simone Filardo; Ombretta Turriziani
Journal:  World J Clin Cases       Date:  2014-07-16       Impact factor: 1.337

Review 8.  Helicobacter pylori infection: new pathogenetic and clinical aspects.

Authors:  Krisztina Hagymási; Zsolt Tulassay
Journal:  World J Gastroenterol       Date:  2014-06-07       Impact factor: 5.742

9.  Association between Helicobacter pylori and mortality in the NHANES III study.

Authors:  Yu Chen; Stephanie Segers; Martin J Blaser
Journal:  Gut       Date:  2013-01-08       Impact factor: 23.059

10.  Antibody levels to persistent pathogens and incident stroke in Mexican Americans.

Authors:  Shawnita Sealy-Jefferson; Brenda W Gillespie; Allison E Aiello; Mary N Haan; Lewis B Morgenstern; Lynda D Lisabeth
Journal:  PLoS One       Date:  2013-06-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.